ABOUT THE PROJECT

Cover art for Journal of Medicinal Chemistry featuring the beautiful work of Upadhaya et al (2022). A fully synthetic and tumor-targeted immune cell agonist, consisting of three bicyclic peptides connected via a branched PEG linker cross-links Nectin-4 on a tumor cell and CD137 on immune cells, resulting in tumor-localized immune agonism.